Evaluation of antinociceptive and anti-inflammatory activities of extract and fractions of Eugenia jambolana root bark and isolation of phytoconstituents  by Saha, Santanu et al.
651
ISSN 0102-695X
DOI: 10.1590/S0102-695X2013005000055
Received 7 Jun 2013
Accepted 24 Jul 2013
Available online 20 Aug 2013
Revista Brasileira de Farmacognosia
Brazilian Journal of Pharmacognosy
23(4): 651-661, Jul./Aug. 2013Evaluation of antinociceptive and anti-
infl ammatory activities of extract and fractions 
of Eugenia jambolana root bark and isolation 
of phytoconstituents
Santanu Saha,*,1 Subrahmanyam E. V. S.,2 Chandrashekar 
Kodangala,3 Shubhash C. Mandal,4 Shashidhara C. Shastry5
1Department of Pharmacognosy, NGSM Institute of Pharmaceutical Sciences, Nitte 
University, India,
2Department of Pharmaceutical Chemistry, Srinivas College of Pharmacy, Vallachil, 
India,
3Department of Pharmacognosy, Manipal College of Pharmaceutical Sciences, Manipal 
University, India,
4Department of Pharmaceutical Technology, Faculty of Engineering and Technology, 
Jadavpur University, India,
5NGSM Institute of Pharmaceutical Sciences, Nitte University, India.
Abstract: Eugenia jambolana Lam., Myrtaceae, is a widely distributed and traditionally 
well known plant in India. The root bark of the plant was extracted with ethanol and 
then successively fractionated into petroleum ether fraction, chloroform fraction, 
n-butanol fraction and methanol fraction. The extract and fractions of the plant material 
were evaluated for the antinociceptive activity by acetic acid-induced writhing test 
and formalin-induced nociception test, and anti-infl ammatory activity was screened by 
carrageenan-induced rat paw edema, cotton pellet induced granuloma formation and 
adjuvant induced arthritis in rat models. The test materials showed the antinociceptive and 
anti-infl ammatory effect in dose dependent manner and the petroleum ether fraction was 
found to be most potent among the test materials. At 400 mg/kg b.w., p.o. dose petroleum 
ether fraction signifi cantly inhibited 54.28% writhing response and 73.77% formalin 
induced nociception in mice. The fraction with same dose showed signifi cant 79.31% 
inhibition of carrageenan-induced rat paw edema, 57.78% anti-proliferative effect and 
77.93% inhibition of adjuvant induced arthritis. The bioactive petroleum ether fraction 
was then subjected to column chromatography which led to isolate three compounds, 
namely, β-sitosterol, stigmasterol and lupeol. These compounds were characterized and 
identifi ed by IR, 1H NMR, 13C NMR and mass spectroscopy.
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Introduction
 Eugenia jambolana Lam., Myrtaceae, is a known 
Indian medicinal plant for traditional uses to treat different 
ailments. This large evergreen tree is distributed through 
out India and commonly known as ‘Jamun’. Root bark of 
the plant is pale brown at inner surface and from outside 
dark brown. Ayurveda and Unani system of medication 
have mentioned variety of therapeutic properties of the 
plant like astringent, carminative, diuretic, antidiabetic, 
anthelmintic, antibacterial, analgesic, anti-infl ammatory, 
antioxidant, as well as gastro protective agents (Kirtikar 
& Basu, 2006). Several phytoconstituents belonging to 
category alkaloids, glycosides, fl avonoids and volatile oil 
has been reported from different parts of plant. Betulinic 
acid, ß-sitosterol, friedelin, epi-friedelanol and fatty acid 
ester of epi-friedelanol (eugenin) has been isolated from 
stem bark of E. jambolana (Sengupta & Das, 1965). 
Quercetin, myricetin, myricitrin, myricetin 3-O-(4”-
acetyl)-α-L-rhamnopyranoside and two acylated fl avonol 
glycosides 3-O-(4"-O-acetyl)-α-L-rhamnopyranoside of 
mearnsetin (myricetin 4'-methyl ether) and myricetin 
3-O-(4"-O-acetyl-2"-O-galloyl)-α-L-rhamnopyranoside 
were isolated from leaves of E. jambolana, in different 
studies (Mahmoud et al., 2001; Timbola et al., 2002). The 
plant is used in treatment of fevers, indigestion, diabetes 
urine related troubles, loss of appetite, loose stools and 
vomiting. The anti-diarrheal, gastroprotective, antidiabetic, 
hypoglycemic and nitric oxide scavenging effects by 
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different parts of this plant have also been reported earlier 
(Ratsimamanga et al., 1972; Mukherjee et al., 1998; 
Jagetia & Balinga, 2004; Sharma et al., 2006; Chaturvedi 
et al., 2007). Traditionally, barks of this plant are used 
for treatment of inflammation (Nadkarni, 2009). Earlier 
studies reported the anti-inflammatory activity by stem 
bark of Eugenia jambolana (Muruganandan et al., 2001). 
As per our knowledge, there are no scientific evidences 
available on antinociceptive and anti-inflammatory activity 
of root bark. Hence, in this study we have evaluated the 
antinociceptive and anti-inflammatory activity of ethanolic 
extract and fractions of root bark of Eugenia jambolana 
and isolated phytoconstituents from active fraction. 
Materials and Methods
General methods
 All the melting points were recorded in a Toshniwal 
melting point apparatus and were uncorrected. IR spectra of 
the compounds were recorded using the KBr pellet method 
on a Perkin Elmer 700 IR spectrophotometer. NMR spectra 
of the compound were taken on Bruker Avance II 400 
NMR spectrometer in CDCl3, at 400 MHz for 
1HNMR and 
100.62 MHz for 13CNMR with tetramethylsilane (TMS) as 
internal standard. EIMS (Electron impact mass spectrum) 
was taken on a Shimadzu LCMS-2010A. TLC was carried 
out using Silica gel 60 F254 plates (Merck). Column 
chromatography was carried out on neutral alumina of 
70-300 mesh from S.D. fine chemicals Pvt. Ltd., Mumbai. 
All the chemicals and reagents used were obtained in high 
purity either from S.D. fine chemicals Pvt. Ltd; Bombay, 
India or E. Merck (India) Ltd., Mumbai.
Plant material
 The root bark of Eugenia jambolana Lam., 
Myrtaceae, were collected from Derelakatte, Mangalore, 
during December 2009 and its botanical identity was 
confirmed by Dr. Noeline J. Pinto Head of Botany 
Department St. Agnes College, Mangalore. A voucher 
specimen (voucher no. 625e) has been deposited in 
NGSM Institute of Pharmaceutical Sciences, Derelakatte, 
Mangalore. 
Extraction and fractionation of plant material
 The shade dried powdered root barks (5 kg) were 
extracted with ethanol (95%) by cold maceration method 
for four times and the extract was concentrated by reduced 
pressure to yield 500 g of crude ethanolic extract. The 
ethanolic extract was suspended in distilled water (1:3, 
v/v) and successively partitioned with petroleum ether 
(60-80 °C, 8x500 mL), chloroform (8x500 mL), n-butanol 
(8x500 mL) and methanol (8x500 mL). The organic layers 
were brought to dryness to yield petroleum ether (35 g), 
chloroform (50 g), n-butanol (55 g) and methanol (70 g) 
fractions.
Animals 
 Studies were carried out by using male Swiss 
albino mice (18-25 g) and male albino Wistar rats (180-200 
g). All animals were obtained from K.S. Hegde Medical 
Academy, Deralakatte, Mangalore. Animals were grouped 
and housed in polyacrylic cages and kept at ambient 
temperature (25±2 ºC), 60±5% relative humidity and 12 h 
light and dark cycle. They had been given standard pellet 
diet (Hindustan Lever Limited, Mumbai, India) and water 
ad libitum throughout the course of the study. The study 
protocols were approved by Institutional Animal Ethical 
Committee (KSHEMA /AEC/077/2008).
Chemicals and drugs
 Carrageenan (Hi–Media Research Laboratories 
Pvt. Ltd., Mumbai), tween 80 (S.D. fine Chemicals Pvt. 
Ltd., Mumbai), Complete Freund’s adjuvant (FCA), 
morphine hydrochloride (Morphine) and indomethacin 
(Indo) (Sigma Aldrich St. Louis, USA). The ethanolic 
extract (EJE) of root bark of E. jambolana and petroleum 
ether fraction (EJPE), chloroform fraction (EJCE), 
n-butanol fraction (EJNB)  and methanol fraction (EJME) 
of ethanolic extract of root bark of E. jambolana were 
used as a suspension in tween 80 (3 mL of 1% solution) 
to screen biological activity. Indomethacin and morphine 
hydrochloride were also used as a suspension in tween 80 
(3 mL of 1% solution).
Acute toxicity study 
 
 Acute toxicity study was conducted to determine 
the median lethal dose (LD50) of test materials EJE, EJPE, 
EJCE, EJNB and EJME, as described in previous study, 
in adult male albino Wistar rats and by following up and 
down procedure of OECD guideline no. 425 (OECD 425, 
2001; Ranawat et al., 2010). Animals were administered 
by test material orally and observed at half hour intervals 
for 4 h, then after 24 h. Test materials were found to be safe 
up to 2000 mg/kg b. w., p.o. dose.
Selection of dose
 The test materials (EJE, EJPE, EJCE, EJNB and 
EJME) did not exhibit any toxic effect up to 2000 mg/kg 
b.w., p.o. dose in acute toxicity study. Hence, for biological 
screening the two doses of test materials were selected 
from the LD50 (2000 mg/kg) in such a manner that middle 
dose was approximately one tenth of the LD50, low dose 
was half of that one tenth dose, and a high dose was twice 
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of that one tenth dose, i.e. 200, 100 and 400 mg/kg b.w., 
p.o. doses, respectively. The antinociceptive and anti-
inflammatory activity studies were carried out by 100, 200 
and 400mg/kg doses of all the test materials EJE, EJPE, 
EJCE, EJNB and EJME. 
Antinociceptive activity studies in mice
 Acetic acid-induced writhing in mice
 Antinociceptive activity of drugs was evaluated 
by the method described earlier (Collier et al., 1968). Male 
Swiss albino mice (18-25 g) were divided in eighteen 
groups (n=10) and respectively treated orally with vehicle 
(tween 80, 3 mL of 1% solution), indomethacin (Indo) 10 
mg/kg b.w., p.o. and 100, 200 and 400 mg/kg b.w., p.o. of 
EJE, EJPE, EJCE, EJNB and EJME at 1 h prior to acetic 
acid injection. Morphine 1 mg/kg b.w. was administered 
intraperitoneally (i.p.) 30 min before the stimulus injection. 
All the animals were injected with 0.6% v/v acetic acid 
by intraperitoneal route and the numbers of writhe were 
counted over the period of 30 min. The percentage 
inhibition of number of writhings were calculated and 
compared with control group. 
Formalin-induced nociception 
 This test was carried out as decribed by Hunskaar 
& Hole (1987). In this experiment mice of respective 
groups (n=10) were treated orally with indomethacin 
(Indo) 10 mg/kg b.w., p.o. and 100, 200 and 400 mg/kg 
b.w., p.o. of EJE, EJPE, EJCE, EJNB and EJME at 1 h prior 
to acetic acid injection. Animals of control group received 
vehicle (tween 80, 3 mL of 1% solution). Morphine 10 
mg/kg b.w. was administered intraperitoneally (i.p.). 
After 1 h of drug treatment, 20 μL of 1% formalin (in 
0.9% saline) were injected in dorsal surface of right hind 
paw of all animals. The animals were placed immediately 
in transparent observation chambers to observe the time 
spent by animals in licking the injected paw during early 
phase (0-5 min) and late phase (20-30 min) after formalin 
injection.
Anti-inflammatory activity studies
 Carrageenan induced rat paw edema
 Acute anti-inflammatory activity of test materials 
(EJE, EJPE, EJCE, EJNB and EJME) were evaluated by 
carrageenan induced rat paw edema study as described by 
Winter et al. (1962). Paw edema was induced by injecting 
0.1 mL of 1% (w/v) carrageenan suspension in 0.9% 
(w/v) sterile saline into the plantar tissue of the left hind 
paw of albino wistar rats. Animals of respective groups 
(n=8) were administered orally with vehicle (tween 80, 3 
mL of 1% solution), indomethacin (Indo) 10 mg/kg b.w., 
p.o. and 100, 200 and 400 mg/kg b.w., p.o. of EJE, EJPE, 
EJCE, EJNB and EJME at 1 h prior to the carrageenan 
induced paw edema. The right paw served as a reference 
to non-inflamed paw for comparison. Then every hour 
relative increase in the paw volume was measured by 
plethysmograph for all groups up to 4 h after carrageenan 
injection. The percentage inhibition of edema volume 
by test materials and standard drug treated groups were 
compared with control group. The percentage inhibition of 
edema volume was calculated using the following formula 
(Suleyman et al., 1991)
Percentage inhibition = (1-Vt/Vc) x100
Where Vt and Vc are the relative changes in the edema of 
the test and control respectively.
 Cotton pellets induced granuloma in rats
 The cotton pellets induced granuloma formation 
in albino wistar rats were carried out by following the 
method described by D’ Arcy et al. (1960). All animals 
were anaesthetized with ether then shaved the fur and 
10 mg of sterile cotton pellets were inserted, one in each 
axilla. Test drugs (EJE, EJPE, EJCE, EJNB and EJME) 
at 100, 200 and 400 mg/kg b.w., p.o. doses and standard 
drug (Indo) at 10 mg/kg b.w., p.o. dose were administered 
orally to animals of respective groups (n=8) for seven days. 
Animals of control groups received vehicle also for seven 
days. On eighth day animals were anaesthetized to remove 
cotton pellets surgically and made free from extraneous 
tissues. The moist pellets were weighed and then dried at 
60 °C for 24 h, after that dried pellets were weighed again. 
Increment in dry weight of pellets was taken as measure of 
granuloma formation. The percentage inhibition of weight 
was calculated and anti-proliferative effect of drug treated 
groups was compared with the control group.
 Adjuvant induced arthritis in rats
 Arthritis was induced by the injection of 0.1 mL 
of Freund’s Complete Adjuvant containing 1 mg/mL of 
heat killed Mycobacterium tuberculosis in paraffin oil and 
mannide monooleate (Sigma Aldrich St. Louis, USA) into 
the subplantar region of right hind paw of rat on day 0 of 
the experiment (Whittington & Green, 1970). On day 0, 2 
h prior to induce arthritis all animals of respective groups 
(n=8) were treated orally with indomethacin (Indo) 10 mg/
kg b.w., p.o. dose, 100, 200 and 400 mg/kg b.w., p.o. doses 
of EJE, EJPE, EJCE, EJNB and EJME and control group 
received vehicle. Treatments were continued till day 14. 
The volume of the paw was measured up to day 14 and 
the percentage inhibition was determined by using formula 
mentioned earlier. 
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Statistical analysis
 Values were expressed as mean±S.E.M. 
Statistical significance was determined by ANOVA, 
followed by Dunnet’s t-test; values with p<0.05 and 
p<0.01 were considered as statistically significant. 
GraphPad Prism version 4.0, GraphPad Software Inc., 
was used for statistical analysis. 
Isolation and characterization of constituents
 Since EJPE (petroleum ether fraction), was 
found to be most active fraction for antinociceptive and 
anti-inflammatory activity, used further for isolation of 
constituents. The petroleum ether fraction was dissolved 
in CHCl3 (30 mL) and adsorbed onto neutral alumina (30 
g). After evaporation of the solvent it was loaded onto 
a silica gel column (150 g) prepared in petroleum ether 
(60-80 ˚C). The column was eluted first with petroleum 
ether (60-80 ˚C) followed by petroleum ether (60-80 
˚C):chloroform graded mixtures (95:5, 90:10, 80:20, 
70:30, 60:40 and 50:50), then with chloroform and finally 
chloroform:methanol (95:5, 90:10, 80:20, 70:30, 60:40 and 
50:50). The elution was monitored by TLC (Silica gel-G: 
visualization by vanillin-sulphuric acid reagent heated at 
110 ºC). Each time 10 mL were collected in a test tube 
and identical elutes (TLC monitored) were combined and 
concentrated to 10 mL and kept in a refrigerator. Three pure 
compounds was isolated respectively by petroleum ether 
(60-80 °C):chloroform grade mixtures (90:10), petroleum 
ether (60-80°C):chloroform (80:20) and petroleum ether 
(60-80°C):chloroform (60:40). 
 Structure elucidation of the isolated compounds 
from petroleum ether fraction was carried out by IR, 1H and 
13C NMR and mass spectrometry (EIMS). By comparing 
the spectral data with the previously reported data these 
compounds were identified as β-sitosterol, stigmasterol 
and lupeol (Wenkert et al., 1978; Khalil & Ldler, 1980; 
Agarwal et al., 1985; Reynolds et al., 1986). 
Results and Discussion
 In the present study, root bark of Eugenia 
jambolana Lam., Myrtaceae, was extracted with ethanol 
and followed by successive fractionation of ethanolic 
extract with petroleum ether (60-80 °C), chloroform, 
n-butanol and methanol. All the extract (EJE) and fractions 
(EJPE, EJCE, EJNB and EJME) were evaluated for 
antinociceptive and anti-inflammatory activity by in vivo 
studies. In acute toxicity study the ethanolic extract (EJE) 
was found to be safe up to 2000 mg /kg b.w., p.o. dose. Thus, 
100, 200 and 400 mg/kg b.w., p.o. doses were selected for 
all the test materials to carry out screening of biological 
activities. The studies to evaluate antinociceptive and anti-
inflammatory effects of root bark of Eugenia jambolana 
were carried out for the first time. 
 Acetic acid induced writhing test is a widely 
employed visceral inflammatory pain model for 
screening of peripherally acting analgesics. In the study, 
injecting acetic acid into the peritoneal cavity of animals 
augments the level of mediators like cytokine, histamine, 
serotonin, bradykinin etc., which are activating peripheral 
nociceptors to persuade writhing response, i.e. episodes of 
stretching of abdomen (Gyires & Torna, 1984; Ikeda et al., 
2001; Lima et al., 2011). Furthermore, acetic acid induces 
prostaglandin biosynthesis which is also the possible 
mechanism for the writhing response (Duarte et al., 1988). 
During the study, analgesic activity of drugs is measured 
by the ability of inhibition of writhing response. In this 
study, test drugs showed dose dependent response. As 
shown in Figure 1, 400 mg/kg b.w., p.o. dose of EJPE and 
EJCE showed the significant (p<0.05) 54.28 and 48.57% 
peripheral antinociceptive effect, respectively, and 400 
mg/kg dose of EJPE was found to be most potent among 
the test materials. Indo 10 mg/kg b.w., p.o. and morphine 1 
mg/kg i.p. doses showed respectively 71.42% and 91.42% 
significant (p<0.01) inhibition of writhing response. 
Hence, the result suggests that the possible mechanism 
for antinociceptive effect of test drug is the inhibition of 
the prostaglandin biosynthesis and the release of those 
inflammatory mediators. The antinociceptive effect of 
test materials were corroborated by formalin induced 
paw licking test. Formalin injection at mice paw 
stimulates the nociception effect by two distinct phases. 
In first phase, formalin directly acts on C-fibers which 
cause acute nociceptive neurogenic pain. Where as the 
late phase correspond inflammatory pain due to release 
of nociceptive mediators and persists for longer period 
(Tjolsen et al., 1992). The late phase is inhibited by 
peripherally acting drugs; where as, drugs act on opioid 
system inhibit the first phase (Shibata et al., 1989).  In 
this study, Indo (10 mg/kg b.w., p.o.) showed significant 
77.51% inhibition (p<0.01) of late phase (Figure 2). 
Among the test materials EJE, EJPE and EJCE at 400 
mg/kg b.w., p.o. dose inhibited significantly (p<0.01) the 
late phase of nociception by 65.47, 73.77 and 69.87%, 
respectively, and EJPE at 400 mg/kg dose was found 
to be most potent among the test materials. But the test 
materials did not show any significant inhibition of first 
phase of nociception. It has been seen that drugs which 
act primarily on central nervous system can inhibit 
both phases (Dubuisson & Dennis, 1977; Rosland et 
al., 1990). In this study, morphine 10 mg/kg i.p. dose 
showed the significant inhibition of early and late 
phase of formalin induced nociception by 91.14% and 
98.36% (p<0.01), respectively. Hence, the result of the 
present study confirmed that the antinociceptive effect 
of test material was due to inhibition of inflammatory 
pain.
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Figure 1. Effects of extract and fractions of Eugenia jambolana 
root bark on acetic-acid induced writhing response in mice model. 
Mice were treated with vehicle (control), indomethacin (Indo) 
10 mg/kg b.w., p.o., morphine 1 mg/kg b.w. intraperitoneally 
(i.p.), ethanolic extract (EJE), petroleum ether fraction (EJPE), 
chloroform fraction (EJCE), n-butanol fraction (EJNB) and 
methanol fraction (EJME) at 100, 200 and 400 mg/kg b.w., 
p.o. doses. Each value represents as mean±SEM. *p<0.05 and 
**p<0.01 as compared with the control group (one-way ANOVA 
followed by Dunnet’s t-test). 
Figure 2. Effects of extract and fractions of Eugenia jambolana 
root bark on formalin induced nociception study in mice. Mice 
were treated with vehicle (control), indomethacin (Indo) 10 mg/
kg b.w., p.o., morphine (Morphi) 10 mg/kg b.w. intraperitoneally 
(i.p.), ethanolic extract (EJE), petroleum ether fraction (EJPE), 
chloroform fraction (EJCE), n-butanol fraction (EJNB) and 
methanol fraction (EJME) at 100, 200 and 400 mg/kg b.w., p.o. 
doses. Antinociceptive effects were observed in early phase 
(0-5 min) and late phase (20-30 min). Each value represents as 
mean±SEM. *p<0.05 and **p<0.01 as compared with the control 
group (one-way ANOVA followed by Dunnet’s t-test).
 The results of antinociceptive activity were 
indicative for anti-infl ammatory properties of test drugs. 
The hypothesis were evaluated by commonly used models 
for screening of anti-infl ammatory activity of drugs, such as, 
carrageenan-induced rat paw edema, cotton pellet induced 
granuloma formation and adjuvant induced arthritis in rat. 
The carrageenan induced rat paw edema is an experimental 
model for acute infl ammation study and which is widely 
used to screen most of the anti-infl ammatory agents. The 
carrageenan induced rat paw edema development is a 
biphasic response, where the initial stage is dependent on 
the release of signature mediators like histamine, kinin and 
bradykinin, and the last phase is attributed to the synthesis 
of prostaglandins (Vinegar et al., 1969; DiRosa et al., 1971). 
Anti-infl ammatory drugs are regulating these mediators to 
reduce edema. Mostly, the anti-infl ammatory drugs are 
found to be effective during late phase, as in this study 
indomethacin showed the inhibition of rat paw edema in 
third and fourth hour. As shown in Table 1, indomethacin 
10 mg/kg showed signifi cant 82.75% (p<0.01) inhibition 
of rat paw edema at 4 h and 71.79% (p<0.05) at 3 h in the 
present study. Like indomethacin, EJPE and EJCE 400 mg/
kg b.w., p.o. doses also respectively exhibited signifi cant 
79.31% (p<0.01) and 72.41% (p<0.01) inhibition of 
rat paw edema at 4 h. During 3 h EJPE 400 mg/kg p.o., 
b.w. dose inhibited edema by 61.53% (p<0.05). Though, 
EJE 400 mg/kg b.w., p.o. dose also showed signifi cant 
68.1% (p<0.05) inhibition at 4 h, EJPE 400 mg/kg dose 
was found to be most potent among all the test materials 
(Figure 3), and this response may be due to the inhibition of 
biosynthesis of prostaglandins (Niemegeers et al., 1964). 
 
Figure 3. Anti-infl ammatory effect of extract and fractions of 
Eugenia jambolana root bark on carragennan-induced rat hind 
paw edema. Effects of indomethacin (Indo) 10 mg/kg b.w., 
p.o., ethanolic extract (EJE), petroleum ether fraction (EJPE), 
chloroform fraction (EJCE), n-butanol fraction (EJNB) and 
methanol fraction (EJME) at 100, 200 and 400 mg/kg b.w., 
p.o. doses were evaluated in the study. Each value represents as 
mean±SEM. *p<0.05 and **p<0.01 as compared with the control 
group (one-way ANOVA followed by Dunnet’s t-test).
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 The cotton pellet induction in rat develops 
granuloma as a sign of chronic inflammation by 
accumulation of macrophages and lymphocytes around 
the foreign particles together with epitheloid and giant 
cells which are derived from macrophages (Swingle & 
Shideman, 1972; Snedegard, 1985; Serhan & Savil, 2005). 
The inhibition of granulomatous tissue formation in rat 
indicates the anti-proliferative effect of drugs, and which is 
measured by percentage inhibition of cotton pellet weight. 
The wet weight of the pellet is influenced by absorption of 
fluid while the dry weight correlates with the amount of 
granulomatous tissue formed (Spector, 1969). As shown in 
Table 2, Indo 10 mg/kg significantly inhibited wet cotton 
pellet weight (62.68%, p<0.01). EJE, EJPE and EJCE 
200 mg/kg b.w., p.o. doses respectively inhibited 31.62, 
35.98 and 24.74% (p<0.05) weight of wet cotton pellet as 
compared to control group (Figure 4). EJE and EJNB 400 
mg/kg b.w., p.o. doses showed 34.57 and 22.63% (p<0.05) 
inhibition of weight of wet cotton pellet, respectively. 
Where as, EJPE and EJCE 400 mg/kg b.w., p.o. doses 
showed significant 57.78 and 50.49% (p<0.01) inhibition 
of wet cotton pellet weight, respectively. Indomethacin (10 
mg/kg) also showed significant inhibition of the weight of 
dry cotton pellets (68.03%, p<0.01) (Table 2). EJPE 400 
mg/kg b.w., p.o. dose showed significant 60.35% (p<0.01) 
inhibition of dry cotton pellets weight, which was closer 
to the result showed by indomethacin (Figure 4). EJE 
and EJCE 400 mg/kg b.w., p.o. doses also significantly 
inhibited 48.41 and 52.66% (p<0.01) weight of dry cotton 
pellets, respectively. Hence, the findings suggested that the 
test drugs significantly (p<0.05 and p<0.01) inhibited the 
proliferative phase of inflammation. 
 The FCA induced arthritis assessed by formation 
of rat paw edema. The chronic inflammation induced by 
adjuvant involved polyartritis in 14th day study (Ward 
& Cloud, 1996). The arthritis was induced in this study 
by a sub-cutaneous injection of FCA, i.e. heat killed 
Mycobacterium tuberculosis in paraffin oil and mannide 
monooleate, in the rat paw’s plantar surface. The arthritis 
was developed in the joints of hind limbs of rats by 
reduction of motor activity and increased paw diameter 
was observed due to inflammation and edema (Calvino 
et al., 1987; Cain et al., 1997). The initial inflammatory 
response was observed within hours, but more critical signs 
of inflammation were developed with days and observed 
till the 14th day of the study. EJPE and EJCE 400 mg/
kg b.w., p.o. doses on day 14th significantly inhibited rat 
paw swelling by 77.93 and 68.27% (p<0.01) respectively 
(Figure 5). Indo 10 mg/kg b.w., p.o. dose significantly 
inhibited the edema by 84.82% (p<0.05) on 14th day of 
study (Table 3). EJE 200 and 400 mg/kg b.w., p.o. doses 
on day 14th showed respectively 46.2 and 64.82% (p<0.05) 
inhibition of edema (Figure 5). EJPE, EJCE and EJNB 
200mg/kg b.w., p.o. doses also showed significant (p<0.05) 
55.17, 50.34 and 40.68% inhibition of adjuvant induced 
rat paw edema, respectively (Figure 5). The test drugs 
Table 1. Anti-inflammatory activity of Eugenia jambolana root bark extracts in carrageenan induced rat paw edema model.
Groups Dose  (mg/kg b.w., p.o.)
Increase in paw volume (mL)
1 h 2 h 3 h 4 h
Control - 0.38±0.13 0.49±0.24 0.78±0.14 1.16±0.11
Indo 10 0.27±0.12 (28.94) 0.34±0.16 (30.61) 0.22±0.13 (71.79)* 0.20±0.17 (82.75)**
EJE
100 0.37±0.16 (2.63) 0.46±0.18  (6.12) 0.71±0.14 (8.97) 0.88±0.10 (24.13)
200 0.35±0.10 (7.89) 0.4±0.12 (18.36) 0.54±0.19 (30.76) 0.65±0.20 (43.96)
400 0.32±0.15 (15.78) 0.36±0.21 (26.53) 0.44±0.11 (43.58) 0.37±0.10 (68.10)*
EJPE
100 0.36±0.18 (5.26) 0.44±0.13 (10.20) 0.69±0.26 (11.53) 0.82±0.15 (29.31)
200 0.33±0.13 (13.15) 0.38±0.19 (22.44) 0.48±0.2 (38.46) 0.63±0.12 (45.68)
400 0.29±0.16 (23.68) 0.37±0.14 (24.48) 0.3±0.18 (61.53)* 0.24±0.11 (79.31)**
EJCE
100 0.37±0.14 (2.63) 0.45±0.18 (8.16) 0.70±0.23 (10.25) 0.86±0.17 (25.86)
200 0.34±0.18 (10.52) 0.42±0.12 (14.28) 0.51±0.16 (34.61) 0.69±0.33 (40.51)
400 0.32±0.17 (15.78) 0.39±0.23 (20.40) 0.41±0.08 (47.43) 0.32±0.20 (72.41)**
EJNB
100 0.37±0.25 (2.63) 0.47±0.12 (4.08) 0.73±0.1 (6.41) 0.91±0.20 (21.55)
200 0.36±0.14 (5.26) 0.45±0.16 (16.32) 0.63±0.22 (19.23) 0.79±0.15 (31.89)
400 0.34±0.16 (10.52) 0.42±0.11 (14.28) 0.59±0.14 (24.35) 0.70±0.06 (39.65)
EJME
100 0.37±0.11 (2.63) 0.48±0.13 (2.04) 0.74±0.15 (5.12) 0.95±0.10 (18.10)
200 0.36±0.14 (5.26) 0.48±0.17 (2.04) 0.67±0.11 (14.10) 0.87±0.14 (25.00)
400 0.35±0.19 (7.89) 0.43±0.12 (12.24) 0.64±0.15 (17.94) 0.74±0.13 (36.20)
All the result are expressed in term of mean±SEM; n=8 animals in each group; number in parenthesis indicates percentage inhibition in increase in paw 
volume. Statistical significance was determined by ANOVA, followed by Dunnet’s t-test. *p<0.05, **p<0.01, statistically significant.
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Table 2. Effects of Eugenia jambolana root bark extracts on cotton pellets induced granuloma formation in rats.
Groups Dose (mg/kg b.w., p.o.)
Moist cotton pellet                                             Dry cotton pellet
Weight (mg) % inhibition Weight (mg) % inhibition
Control - 295.63±14.53 - 84.37±3.00 -
Indo 10 110.32±9.07 62.68** 26.97±1.34 68.03**
EJE
100 262.74±16.71 11.12 72.53±1.56 14.03
200 202.15±10.35 31.62* 59.24±2.03 29.78**
400 193.43±11.63 34.57* 43.52±1.80 48.41**
EJPE
100 258.29±8.11 12.63 68.11±2.35 19.27
200 189.26±17.66 35.98* 48.25±2.41 42.81**
400 124.81±19.81 57.78** 33.45±3.26 60.35**
EJCE
100 265.13±14.32 10.31 70.84±1.78 16.03
200 222.49±18.26 24.74* 61.23±2.05 27.42**
400 146.35±13.74 50.49** 39.94±1.93 52.66**
EJNB
100 272.48±12.60 7.83 75.27±1.22 10.78
200 244.69±15.47 17.23 73.42±1.63 12.97
400 228.72±16.93 22.63* 66.98±2.11 20.61*
EJME
100 283.14±23.58 4.22 78.51±1.88 6.94
200 263.34±19.64 10.92 75.82±1.54 10.13
400 246.58±10.33 16.59 71.57±2.47 15.17
All the result are expressed in term of mean±SEM. n=8 animals in each group; Statistical signifi cance was determined by ANOVA, followed by 
Dunnet’s t-test. *p<0.05, **p<0.01, statistically signifi cant. 
Figure 4. Effects of extract and fractions of Eugenia jambolana root bark on cotton pellet induced granuloma in rat. Anti-proliferative 
effect of indomethacin (Indo) 10 mg/kg b.w., p.o., ethanolic extract (EJE), petroleum ether fraction (EJPE), chloroform fraction 
(EJCE), n-butanol fraction (EJNB) and methanol fraction (EJME) at 100, 200 and 400 mg/kg b.w., p.o. doses were evaluated by 
weighing moist and dry cotton pellets. Each value represents as mean±SEM. *p<0.05 and **p<0.01 as compared with the control 
group (one-way ANOVA followed by Dunnet’s t-test).
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Table 3. Anti-infl ammatory activity of Eugenia jambolana root bark extracts in adjuvant induced arthritis in rats. 
Groups Dose (mg/kg b.w., p.o.)
Increase in paw volume (mL)
0 day 3 day 7 day 14 day
Control - 0.42±0.20 0.57±0.13 0.82±0.19 1.45±0.12
Indo 10 0.38±0.16 (9.52) 0.46±0.12 (19.29) 0.37±0.13 (54.87) 0.22±0.11 (84.82)**
EJE
100 0.42±0.15 (0.00) 0.56±0.27 (1.75) 0.77±0.14 (6.09) 1.09±0.09 (24.82)
200 0.40±0.12 (4.76) 0.53±0.1 (7.01) 0.74±0.19 (9.75) 0.78±0.15 (46.2)*
400 0.39±0.21 (7.14) 0.51±0.15 (10.52) 0.61±0.11 (25.61) 0.51±0.14 (64.82)*
EJPE
100 0.42±0.1 (0.00) 0.55±0.23 (3.5) 0.76±0.17 (7.31) 0.93±0.13 (35.86)
200 0.41±0.19 (2.38) 0.54±0.13 (5.26) 0.74±0.2 (9.75) 0.65±0.16 (55.17)*
400 0.39±0.14 (7.14) 0.5±0.16 (12.28) 0.56±0.18 (31.7) 0.32±0.10 (77.93)**
EJCE
100 0.42±0.15 (0.00) 0.56±0.24 (1.75) 0.77±0.13 (6.09) 0.97±0.12 (33.1)
200 0.42±0.12 (0.00) 0.55±0.18 (3.5) 0.76±0.16 (7.31) 0.72±0.18 (50.34)*
400 0.4±0.23 (4.76) 0.52±0.17 (8.77) 0.60±0.08 (26.82) 0.46±0.12 (68.27)**
EJNB
100 0.42±0.08 (0.00) 0.56±0.06 (1.75) 0.79±0.13 (3.65) 1.17±0.29 (19.31)
200 0.42±0.16 (0.00) 0.55±0.14 (3.5) 0.77±0.22 (6.09) 0.86±0.15 (40.68)*
400 0.41±0.11 (2.38) 0.54±0.16 (5.26) 0.64±0.14 (21.95) 0.79±0.09 (45.51)*
EJME
100 0.42±0.15 (0.00) 0.57±0.13 (0.00) 0.80±0.26 (2.43) 1.23±0.30 (15.17)
200 0.42±0.17 (0.00) 0.56±0.14 (1.75) 0.77±0.11 (6.09) 0.91±0.14 (37.24)
400 0.41±0.14 (2.38) 0.55±0.09 (3.5) 0.68±0.17 (17.07) 0.82±0.19 (43.44)*
All the result are expressed in term of mean±SEM.; n=8 animals in each group; number in parenthesis indicates percentage inhibition in increase in 
paw volume. Statistical signifi cance was determined by ANOVA, followed by Dunnet’s t-test. *p<0.05, **p<0.01, statistically signifi cant. 
Figure 5. Effects of extract and fractions of Eugenia jambolana root bark on adjuvant induced arthritis in rat. The anti-arthritic 
activity of indomethacin (Indo) 10 mg/kg b.w., p.o., ethanolic extract (EJE), petroleum ether fraction (EJPE), chloroform fraction 
(EJCE), n-butanol fraction (EJNB) and methanol fraction (EJME) at 100, 200 and 400 mg/kg b.w., p.o. doses were evaluated by 
reduction of adjuvant induced rat hind paw edema. Each value represents as mean±SEM. *p<0.05 and **p<0.01 as compared with 
the control group (one-way ANOVA followed by Dunnet’s t-test).
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showed the efficacy during the study and EJPE 400 mg/kg 
b.w., p.o. dose showed the maximum reduction of rat paw 
edema among the other doses (Table 3) which was also 
comparable to the effect of standard drug. The inhibition 
of rat paw edema was indicated the therapeutic efficacy of 
the test drug in chronic inflammatory state and the effect 
was observed may be due to the inhibition of prostaglandin 
biosynthesis (Babu et al., 2009). 
 Therefore, these results suggested that the test 
materials exhibited significant antinociceptive and anti-
inflammatory effect and EJPE (400 mg/kg b.w., p.o. dose) 
was found to be most potent among all the test materials. 
Hence, the current study has qualified the traditional 
claim for anti-inflammatory effect by Eugenia jambolana. 
Furthermore, the bioactive petroleum ether fraction of 
ethanolic extract of root bark of Eugenia jambolana 
(EJPE) was subjected to column chromatography which 
led to isolate three pure compounds.  These compounds 
were characterized by IR, 1H and 13C NMR and mass 
spectroscopy. These compounds were identified as 
β-sitosterol, stigmasterol and lupeol by comparing with 
previously reported spectroscopical data. Nevertheless, 
by comparison with the previous reports the findings 
suggested that the antinociceptive and anti-inflammatory 
activities of petroleum ether fraction of ethanolic extract 
of root bark of Eugenia jambolana may be due to the 
presence of these compounds (Garcia et al., 1999; Navarro 
et al., 2001; Geetha & Varalakshmi, 2001; Backhouse et 
al., 2008). Therefore, the further studies on antinociceptive 
and anti-inflammatory activities need to be performed with 
these isolated compounds.
Conclusion
 The antinociceptive and anti-inflammatory 
activity of ethanolic extract and different fractions of root 
bark of Eugenia jambolana were evaluated in the present 
study. The bioassay potential petroleum ether fraction was 
led to isolate β-sitosterol, stigmasterol and lupeol. Hence, 
these findings suggested the significant antinociceptive 
and anti-inflammatory effects of root bark of Eugenia 
jambolana. However, the mechanisms underlying the 
antinociceptive and anti-inflammatory effects of Eugenia 
jambolana is still needed to be determined.
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